Speculation is building that President Donald Trump may delay the introduction of his 100% tariff rate on pharmaceutical imports in order to negotiate more deals with drugmakers on drug pricing. The ...
Two weeks ago, the US FDA announced a crackdown on direct-to-consumer advertising, causing significant consternation for the pharma industry, not to mention the sizeable sub-industry that is pharma ...